Clinical Trials Directory

Trials / Completed

CompletedNCT04871971

Glycaemic Response and Insulinaemic Response for Nutralys S85 Plus and Whey Protein

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Oxford Brookes University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

A comparison of the glycaemic response and insulinaemic response to glucose, Nutralys S85 Plus pea protein and whey protein using a single-blind, randomised, repeat measure, crossover design trial.

Detailed description

A single-blind, randomised, repeat measure, crossover design trial will be used to study the glycaemic response and insulinaemic response following consumption of five products: one reference product (50 g available carbohydrate Glucose) and four test products (50 g available carbohydrate Glucose with 10 g NUTRALYS®S85 Plus pea protein, 50 g available carbohydrate Glucose with 20 g NUTRALYS®S85 Plus pea protein, 50 g available carbohydrate Glucose with 10 g Whey protein concentrate and 50 g available carbohydrate Glucose with 20 g Whey protein concentrate).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT10 g NUTRALYS®S85 Plus pea proteinTo determine the glycaemic response and insulinaemic response to 50g Glucose + 10 g NUTRALYS®S85 Plus pea protein.
DIETARY_SUPPLEMENT20 g NUTRALYS®S85 Plus pea proteinTo determine the glycaemic response and insulinaemic response to 50g Glucose + 20 g NUTRALYS®S85 Plus pea protein.
DIETARY_SUPPLEMENT10 g Whey protein concentrateTo determine the glycaemic response and insulinaemic response to 50g Glucose + 10 g Whey protein concentrate.
DIETARY_SUPPLEMENT20 g Whey protein concentrateTo determine the glycaemic response and insulinaemic response to 50g Glucose + 20 g Whey protein concentrate.
DIETARY_SUPPLEMENT50 g GlucoseTo determine the glycaemic response and insulinaemic response to 50g Glucose

Timeline

Start date
2021-09-15
Primary completion
2022-07-13
Completion
2022-08-29
First posted
2021-05-04
Last updated
2022-09-07

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04871971. Inclusion in this directory is not an endorsement.